Clinical Trial Update: Symbicort Turbuhaler 30/60 Specific Clinical Experience Investigation

View source ↗

Summary

This document summarizes a completed clinical trial evaluating Symbicort Turbuhaler 30/60 in patients with asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Symbicort Turbuhaler 30/60 (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Bronchial Asthma | Status: COMPLETED